These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18640245)

  • 1. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Feng HL; Leng Y; Ma CH; Zhang J; Ren M; Chuang DM
    Neuroscience; 2008 Aug; 155(3):567-72. PubMed ID: 18640245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
    Wang SY; Ren M; Jiang HZ; Wang J; Jiang HQ; Yin X; Qi Y; Wang XD; Dong GT; Wang TH; Yang YQ; Feng HL
    Neuroscience; 2015 Aug; 301():276-88. PubMed ID: 26067594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
    Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
    J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid.
    Jiang HZ; Wang SY; Yin X; Jiang HQ; Wang XD; Wang J; Wang TH; Qi Y; Yang YQ; Wang Y; Zhang CT; Feng HL
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats.
    Sharma S; Taliyan R
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Mar; 388(3):337-49. PubMed ID: 25547373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
    Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
    J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of valproic acid in suppressing disease progression of ALS model mice.
    Sugai F; Yamamoto Y; Miyaguchi K; Zhou Z; Sumi H; Hamasaki T; Goto M; Sakoda S
    Eur J Neurosci; 2004 Dec; 20(11):3179-83. PubMed ID: 15579172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury.
    Yu F; Wang Z; Tanaka M; Chiu CT; Leeds P; Zhang Y; Chuang DM
    J Neurosurg; 2013 Sep; 119(3):766-73. PubMed ID: 23848820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
    Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
    Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocarboxylate transporter functions and neuroprotective effects of valproic acid in experimental models of amyotrophic lateral sclerosis.
    Gyawali A; Latif S; Choi SH; Hyeon SJ; Ryu H; Kang YS
    J Biomed Sci; 2022 Jan; 29(1):2. PubMed ID: 35012534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS.
    Koh SH; Kim Y; Kim HY; Hwang S; Lee CH; Kim SH
    Exp Neurol; 2007 Jun; 205(2):336-46. PubMed ID: 17433298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhao Z; Fu J; Li S; Li Z
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis.
    Teng YD; Choi H; Huang W; Onario RC; Frontera WR; Snyder EY; Sabharwal S
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):155-8. PubMed ID: 16388902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Petri S; Kipiani K; Gardian G; Choi DK; Chen J; Calingasan NY; Schafer P; Muller GW; Stewart C; Hensley K; Beal MF
    J Neurosci; 2006 Mar; 26(9):2467-73. PubMed ID: 16510725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease.
    Chiu CT; Liu G; Leeds P; Chuang DM
    Neuropsychopharmacology; 2011 Nov; 36(12):2406-21. PubMed ID: 21796107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.